EE571 Cost-Effectiveness of Maribavir for Post-Transplant Refractory Cytomegalovirus Infection With or Without Resistan A UK Perspective
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.811
https://www.valueinhealthjournal.com/article/S1098-3015(22)03015-7/fulltext
Title :
EE571 Cost-Effectiveness of Maribavir for Post-Transplant Refractory Cytomegalovirus Infection With or Without Resistan A UK Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03015-7&doi=10.1016/j.jval.2022.09.811
First page :
Section Title :
Open access? :
No
Section Order :
10351